Gradalis, Inc’s FANG Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer

Read about how Dallas-based Gradalis, Inc’s FANG Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer

http://bionews-tx.com/news/2013/05/16/gradalis-incs-fang-personalized-tumor-vaccine-stimulates-immune-response-and-more-than-doubles-time-to-recurrence-in-patients-with-advanced-stage-ovarian-cancer/

Texas Company Pioneering Personalized DNA Sequencing Contributes to Genetic Disease Research in Jewish Population

Read about how a Texas Company Pioneering Personalized DNA Sequencing Contributes to Genetic Disease Research in Jewish Population.

http://bionews-tx.com/news/2013/04/26/texas-company-pioneering-personalized-dna-sequencing-contributes-to-genetic-disease-research-in-jewish-population/